Camp4 Therapeutics Corporation

This early-stage study tests a new drug, CMP-CPS-001, given as a shot under the skin. It includes 120 healthy adults and people with a genetic condition called OTC deficiency, which affects the liver's ability to remove ammonia from the body. The main goal is to check safety and …